SWS Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SWS Partners's AMGN Position: Q3 2026 in Review
SWS Partners reduced its Amgen (AMGN) stake by 1.9% in Q3 2026, selling an estimated $7.17K and leaving 910 shares worth $384K. The position accounts for 0.08% of the portfolio, ranked #98.
SWS Partners first reported a position in AMGN in Q4 2017 and has held it in 16 quarters since. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- SWS Partners held 910 shares of Amgen worth $384K as of Q3 2026.
- SWS Partners sold 18 Amgen shares in Q3 2026, an estimated $7.17K.
- Amgen made up 0.08% of SWS Partners's portfolio in Q3 2026, its #98 holding.
- SWS Partners first reported a position in Amgen in Q4 2017 and has held it in 16 quarters since.
- 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on SWS Partners's 13F filing for Q3 2026, filed 26 Oct 2026.